// App-Quantinova.ai

4133 : Suppressed B7-H3 expression reduces glycolytic capacity and sensitizes tumor cells to anti-cancer agents

Researchers

Presenter

  • Caroline E. Nunes-Xavier

Principal Investigators

  • Karine Flem Karlsen

  • Tove yjord

  • Ming Tan

  • ystein Fodstad

Medical Centers

  • Institute for Cancer Research, Oslo, Norway.

  • Center for Cell Death and Metabolism, Mitchell Cancer Institute, University of South Alabama, Mobile, AL.

Locations

  • United States

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Serine/threonine-protein kinase mTOR

  • PI3K/AKT

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved